Trevena Inc. (TRVN) NASDAQ
$0.26 0 (0.27%)
Market Cap: $44.22M
As of 08/15/22 11:05 AM EDT. Market open.
Trevena Inc. (TRVN) NASDAQ
$0.26 0 (0.27%)
Market Cap: $44.22M
As of 08/15/22 11:05 AM EDT. Market open.
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK™ (oliceridine) injection, indicated inadults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are ... read more
Trevena, Inc. is a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with CNS disorders. The Company has one approved product in the United States, OLINVYK™ (oliceridine) injection, indicated inadults for the management of acute pain severe enough to require an intravenous opioid analgesic and for whom alternative treatments are inadequate. The Company also has four novel and differentiated investigational drug candidates: TRV250 for the acute treatment of migraine, TRV734 for maintenance treatment of opioid use disorder, and TRV027 for acute lung injury / abnormal blood clotting in COVID-19 patients. The Company has also identified TRV045, a novel S1P receptor modulator that may offer a new approach to treating a variety of CNS disorders. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carrie Bourdow
Full Time Employees
25
CEO Compensation (Base)
$536,667
CEO Compensation (Total)
$2.81M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO
Carrie Bourdow
Full Time Employees
25
CEO Compensation (Base)
$536,667
CEO Compensation (Total)
$2.81M
URL
Address
955 Chesterbrook Blvd Ste 110, Pennsylvania, Chesterbrook, 19087-5627.
PRICE CHART
From:
To:
NEWS
KEY STATS
Open
$0.25
Previous Close
$0.25
Days Range
$0.24 - $0.26
52 week range
$0.18 - $1.40
Volume
204,657
Avg. Volume (30 days)
1,433,959
Market Cap
$44.22M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
173,681,085
Open
$0.25
Previous Close
$0.25
Days Range
$0.24 - $0.26
52 week range
$0.18 - $1.40
Volume
204,657
Avg. Volume (30 days)
1,433,959
Market Cap
$44.22M
Dividend Yield
0.00%
P/E
-
Shares Outstanding
173,681,085
Open in:
Open in:
INSIDER TRANSACTIONS FOR TREVENA INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Shin Barry | SVP, CFO | Jun 28, 2022 | Sale | $0.41 | 31,785 | 13,032 | 873,056 | Jun 29, 2022, 05:12 PM |
| Bourdow Carrie L. | President & CEO | Dec 17, 2021 | Option Exercise | $0.70 | 33,546 | 23,482 | 2,424,403 | Dec 21, 2021, 04:17 PM |
| Demitrack Mark | SVP, Chief Medical Officer | Dec 17, 2021 | Option Exercise | $0.70 | 12,408 | 8,686 | 791,172 | Dec 21, 2021, 04:16 PM |
| Yoder Robert T | SVP, Chief Business Officer | Dec 17, 2021 | Option Exercise | $0.70 | 9,711 | 6,798 | 565,205 | Dec 21, 2021, 04:11 PM |
| Shin Barry | SVP, CFO | Dec 17, 2021 | Option Exercise | $0.70 | 14,216 | 9,951 | 904,841 | Dec 21, 2021, 04:10 PM |
| Demitrack Mark | SVP, Chief Medical Officer | Dec 06, 2021 | Option Exercise | $0.65 | 30,601 | 19,891 | 803,580 | Dec 08, 2021, 04:17 PM |
| Yoder Robert T | SVP, Chief Business Officer | Dec 06, 2021 | Option Exercise | $0.65 | 22,950 | 14,917 | 574,916 | Dec 08, 2021, 04:17 PM |
| Shin Barry | SVP, CFO & CCO | Dec 06, 2021 | Option Exercise | $0.65 | 34,408 | 22,365 | 919,057 | Dec 08, 2021, 04:16 PM |
| Bourdow Carrie L. | President & CEO | Dec 06, 2021 | Option Exercise | $0.65 | 93,561 | 60,815 | 2,457,949 | Dec 08, 2021, 04:16 PM |
| Bourdow Carrie L. | President & CEO | Jun 28, 2021 | Buy | $1.79 | 56,200 | 100,542 | 1,301,510 | Jun 28, 2021, 05:33 PM |
| Shin Barry | Chief Financial Officer | Jun 25, 2021 | Option Exercise | $1.96 | 24,635 | 48,285 | 535,965 | Jun 25, 2021, 05:49 PM |
| Applebaum Scott | CLCO; SVP, Regulatory Affairs | Feb 10, 2021 | Option Exercise | $2.85 | 21,178 | 60,357 | 344,022 | Feb 12, 2021, 04:17 PM |
| Bourdow Carrie L. | President & CEO | Dec 07, 2020 | Option Exercise | $2.27 | 151,684 | 344,323 | 1,245,310 | Dec 31, 2020, 04:52 PM |
| Yoder Robert T | Sr VP Chief Commercial Officer | Dec 07, 2020 | Option Exercise | $2.27 | 36,688 | 83,282 | 216,566 | Dec 09, 2020, 04:43 PM |
| Demitrack Mark | Sr. VP & Chief Medical Officer | Dec 07, 2020 | Option Exercise | $2.27 | 48,557 | 110,224 | 271,481 | Dec 09, 2020, 04:38 PM |
| Bourdow Carrie L. | President & CEO | Dec 07, 2020 | Option Exercise | $2.27 | 132,934 | 301,760 | 792,960 | Dec 09, 2020, 04:37 PM |
| Shin Barry | Chief Financial Officer | Dec 07, 2020 | Option Exercise | $2.27 | 41,861 | 95,024 | 403,600 | Dec 09, 2020, 04:35 PM |
| Shin Barry | Chief Financial Officer | Jun 25, 2020 | Option Exercise | $1.72 | 23,539 | 40,487 | 445,461 | Jun 29, 2020, 07:49 PM |
| Yoder Robert T | Sr. VP, Chief Business Officer | Dec 02, 2019 | Option Exercise | $0.69 | 6,874 | 4,735 | 86,254 | Dec 04, 2019, 05:48 PM |
| Demitrack Mark | Sr. VP & Chief Medical Officer | Dec 02, 2019 | Option Exercise | $0.69 | 8,982 | 6,188 | 107,038 | Dec 04, 2019, 05:47 PM |
| Bourdow Carrie L. | President and CEO | Dec 02, 2019 | Option Exercise | $0.69 | 17,804 | 12,265 | 268,894 | Dec 04, 2019, 05:46 PM |
| Demitrack Mark | Sr VP & Chief Medical Officer | Jun 03, 2019 | Option Exercise | $1.17 | 8,980 | 10,507 | 116,020 | Jun 04, 2019, 04:53 PM |
| Hamill John P. | VP Fin,Princ Fin&Acct Officer | Jun 03, 2019 | Option Exercise | $1.17 | 5,516 | 6,454 | 82,234 | Jun 04, 2019, 04:52 PM |
| Hamill John P. | VP Fin,Princ Fin&Acct Officer | May 31, 2019 | Buy | $1.16 | 7,500 | 8,700 | 87,750 | Jun 04, 2019, 04:52 PM |
| Yoder Robert T | Sr. VP, Chief Business Officer | Jun 03, 2019 | Option Exercise | $1.17 | 6,872 | 8,040 | 93,128 | Jun 04, 2019, 04:51 PM |
| Bourdow Carrie L. | President and CEO | Jun 03, 2019 | Option Exercise | $1.17 | 17,802 | 20,828 | 286,698 | Jun 04, 2019, 04:49 PM |
| GOWEN MAXINE | President & CEO | Feb 01, 2019 | Buy | $1.02 | 50,000 | 51,000 | 54,000 | Feb 05, 2019, 04:59 PM |
| Bourdow Carrie L. | President and CEO | Feb 01, 2019 | Option Exercise | $1.02 | 50,000 | 51,000 | 304,500 | Feb 05, 2019, 08:41 AM |
| MOULDER LEON O JR | Director | Feb 01, 2019 | Buy | $1.02 | 100,000 | 102,000 | 100,000 | Feb 04, 2019, 09:01 AM |
| Habib Yacoub | SVP, Bus Dev & Corp Planning | Mar 22, 2018 | Sale | $1.76 | 5,000 | 8,800 | 0 | Mar 23, 2018, 05:16 PM |
| GOWEN MAXINE | President & CEO | Feb 23, 2017 | Option Exercise | $0.68 | 110,403 | 75,295 | 126,903 | Feb 27, 2017, 08:34 AM |
| Lark Michael W. | Sr. VP, Research & CSO | Feb 10, 2017 | Option Exercise | $0.68 | 12,815 | 8,740 | 98,460 | Feb 14, 2017, 05:20 PM |
| Lark Michael W. | Sr. VP, Research & CSO | Feb 10, 2017 | Sale | $8.00 | 23,699 | 189,592 | 74,761 | Feb 14, 2017, 05:20 PM |
| Bourdow Carrie L. | SVP, Chief Commercial Officer | Nov 09, 2016 | Buy | $4.34 | 4,000 | 17,360 | 4,500 | Nov 10, 2016, 06:12 PM |
| GOWEN MAXINE | President & CEO | Nov 07, 2016 | Buy | $4.10 | 12,500 | 51,250 | 16,500 | Nov 09, 2016, 05:37 PM |
| Habib Yacoub | SVP, Bus Dev & Corp Planning | Nov 07, 2016 | Buy | $4.12 | 5,000 | 20,600 | 5,000 | Nov 09, 2016, 05:36 PM |
| GOWEN MAXINE | President & CEO | May 27, 2016 | Buy | $7.08 | 14,084 | 99,715 | 293,109 | May 31, 2016, 05:34 PM |
| GOWEN MAXINE | President & CEO | May 26, 2016 | Buy | $7.20 | 4,000 | 28,800 | 4,000 | May 31, 2016, 05:34 PM |
| GOWEN MAXINE | President & CEO | May 26, 2016 | Buy | $7.19 | 4,000 | 28,760 | 279,025 | May 31, 2016, 05:34 PM |
| Soergel David | Sr. VP,Clinical Dev. & CMO | Dec 10, 2015 | Sale | $10.55 | 27,217 | 287,139 | 1,750 | Dec 11, 2015, 05:17 PM |
| Limongelli John M | Sr. VP,General Counsel & Secy | Dec 12, 2014 | Buy | $4.14 | 3,000 | 12,420 | 12,000 | Dec 15, 2014, 05:00 PM |
| MOULDER LEON O JR | Director | Dec 09, 2014 | Buy | $3.96 | 30,200 | 119,592 | 30,200 | Dec 10, 2014, 08:39 PM |
| MOULDER LEON O JR | Director | Dec 10, 2014 | Buy | $4.06 | 19,800 | 80,388 | 50,000 | Dec 10, 2014, 08:39 PM |
| Soergel David | Sr. VP, Clinical Development | Dec 10, 2014 | Buy | $4.00 | 1,250 | 5,000 | 28,967 | Dec 10, 2014, 08:37 PM |
| Soergel David | Sr. VP, Clinical Development | Dec 09, 2014 | Buy | $3.97 | 500 | 1,985 | 27,717 | Dec 10, 2014, 08:37 PM |
| Limongelli John M | Sr. VP,General Counsel & Secy | Dec 10, 2014 | Buy | $4.00 | 9,000 | 36,000 | 9,000 | Dec 10, 2014, 06:07 PM |
| Cuca Roberto | Sr. VP and CFO | Dec 10, 2014 | Buy | $4.00 | 25,000 | 100,000 | 25,000 | Dec 10, 2014, 06:05 PM |
| Yanni Barbara | Director | Dec 10, 2014 | Buy | $4.00 | 1,250 | 5,000 | 1,250 | Dec 10, 2014, 06:03 PM |
| DOUGHERTY MICHAEL R | Director | Dec 10, 2014 | Buy | $4.00 | 7,000 | 28,000 | 7,000 | Dec 10, 2014, 06:01 PM |
| Soergel David | Sr. VP, Clinical Development | Dec 10, 2014 | Buy | $4.00 | 1,250 | 5,000 | 28,467 | Dec 10, 2014, 05:59 PM |
| Lark Michael W. | Sr. VP, Research & CSO | Dec 10, 2014 | Buy | $4.00 | 5,000 | 20,000 | 85,645 | Dec 10, 2014, 05:56 PM |
| GOWEN MAXINE | President & CEO | Dec 10, 2014 | Buy | $4.00 | 8,000 | 32,000 | 326,025 | Dec 10, 2014, 05:54 PM |
| Alta Partners VIII, L.P. | 10% Owner | Dec 10, 2014 | Buy | $4.00 | 500,000 | 2,000,000 | 4,390,262 | Dec 10, 2014, 05:51 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Dec 10, 2014 | Buy | $4.00 | 1,000,000 | 4,000,000 | 4,811,691 | Dec 10, 2014, 12:13 PM |
| Deegan Rosamond | Sr VP, Bus Dev & Operations | Sep 29, 2014 | Sale | $7.00 | 44 | 308 | 31,105 | Oct 01, 2014, 04:48 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Aug 14, 2014 | Sale | $6.04 | 36,702 | 221,680 | 3,637,115 | Aug 18, 2014, 04:30 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Aug 13, 2014 | Sale | $6.12 | 5,700 | 34,884 | 3,672,530 | Aug 15, 2014, 04:30 PM |
| GOWEN MAXINE | President & CEO | Apr 23, 2014 | Option Exercise | $0.68 | 124,477 | 84,893 | 318,025 | May 15, 2014, 09:37 PM |
| Forest Laboratories Holdings Ltd | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 428,571 | 2,999,997 | 3,393,466 | Feb 07, 2014, 01:14 PM |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 472,410 | 3,306,870 | 3,811,691 | Feb 07, 2014, 12:16 PM |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 472,405 | 3,306,835 | 3,811,682 | Feb 07, 2014, 12:06 PM |
| HealthCare Ventures VIII, L.P. | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 297,058 | 2,079,406 | 2,446,251 | Feb 07, 2014, 12:02 PM |
| Alta Partners VIII, L.P. | 10% Owner | Feb 05, 2014 | Buy | $7.00 | 472,410 | 3,306,870 | 3,890,262 | Feb 07, 2014, 11:57 AM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Shin Barry | SVP, CFO | 06/28/2022 | 13,032 |
| Bourdow Carrie L. | President & CEO | 12/17/2021 | 23,482 |
| Demitrack Mark | SVP, Chief Medical Officer | 12/17/2021 | 8,686 |
| Yoder Robert T | SVP, Chief Business Officer | 12/17/2021 | 6,798 |
| Shin Barry | SVP, CFO | 12/17/2021 | 9,951 |
| Demitrack Mark | SVP, Chief Medical Officer | 12/06/2021 | 19,891 |
| Yoder Robert T | SVP, Chief Business Officer | 12/06/2021 | 14,917 |
| Shin Barry | SVP, CFO & CCO | 12/06/2021 | 22,365 |
| Bourdow Carrie L. | President & CEO | 12/06/2021 | 60,815 |
| Bourdow Carrie L. | President & CEO | 06/28/2021 | 100,542 |
| Shin Barry | Chief Financial Officer | 06/25/2021 | 48,285 |
| Applebaum Scott | CLCO; SVP, Regulatory Affairs | 02/10/2021 | 60,357 |
| Bourdow Carrie L. | President & CEO | 12/07/2020 | 344,323 |
| Yoder Robert T | Sr VP Chief Commercial Officer | 12/07/2020 | 83,282 |
| Demitrack Mark | Sr. VP & Chief Medical Officer | 12/07/2020 | 110,224 |
| Bourdow Carrie L. | President & CEO | 12/07/2020 | 301,760 |
| Shin Barry | Chief Financial Officer | 12/07/2020 | 95,024 |
| Shin Barry | Chief Financial Officer | 06/25/2020 | 40,487 |
| Yoder Robert T | Sr. VP, Chief Business Officer | 12/02/2019 | 4,735 |
| Demitrack Mark | Sr. VP & Chief Medical Officer | 12/02/2019 | 6,188 |
| Bourdow Carrie L. | President and CEO | 12/02/2019 | 12,265 |
| Demitrack Mark | Sr VP & Chief Medical Officer | 06/03/2019 | 10,507 |
| Hamill John P. | VP Fin,Princ Fin&Acct Officer | 06/03/2019 | 6,454 |
| Hamill John P. | VP Fin,Princ Fin&Acct Officer | 05/31/2019 | 8,700 |
| Yoder Robert T | Sr. VP, Chief Business Officer | 06/03/2019 | 8,040 |
| Bourdow Carrie L. | President and CEO | 06/03/2019 | 20,828 |
| GOWEN MAXINE | President & CEO | 02/01/2019 | 51,000 |
| Bourdow Carrie L. | President and CEO | 02/01/2019 | 51,000 |
| MOULDER LEON O JR | Director | 02/01/2019 | 102,000 |
| Habib Yacoub | SVP, Bus Dev & Corp Planning | 03/22/2018 | 8,800 |
| GOWEN MAXINE | President & CEO | 02/23/2017 | 75,295 |
| Lark Michael W. | Sr. VP, Research & CSO | 02/10/2017 | 8,740 |
| Lark Michael W. | Sr. VP, Research & CSO | 02/10/2017 | 189,592 |
| Bourdow Carrie L. | SVP, Chief Commercial Officer | 11/09/2016 | 17,360 |
| GOWEN MAXINE | President & CEO | 11/07/2016 | 51,250 |
| Habib Yacoub | SVP, Bus Dev & Corp Planning | 11/07/2016 | 20,600 |
| GOWEN MAXINE | President & CEO | 05/27/2016 | 99,715 |
| GOWEN MAXINE | President & CEO | 05/26/2016 | 28,800 |
| GOWEN MAXINE | President & CEO | 05/26/2016 | 28,760 |
| Soergel David | Sr. VP,Clinical Dev. & CMO | 12/10/2015 | 287,139 |
| Limongelli John M | Sr. VP,General Counsel & Secy | 12/12/2014 | 12,420 |
| MOULDER LEON O JR | Director | 12/09/2014 | 119,592 |
| MOULDER LEON O JR | Director | 12/10/2014 | 80,388 |
| Soergel David | Sr. VP, Clinical Development | 12/10/2014 | 5,000 |
| Soergel David | Sr. VP, Clinical Development | 12/09/2014 | 1,985 |
| Limongelli John M | Sr. VP,General Counsel & Secy | 12/10/2014 | 36,000 |
| Cuca Roberto | Sr. VP and CFO | 12/10/2014 | 100,000 |
| Yanni Barbara | Director | 12/10/2014 | 5,000 |
| DOUGHERTY MICHAEL R | Director | 12/10/2014 | 28,000 |
| Soergel David | Sr. VP, Clinical Development | 12/10/2014 | 5,000 |
| Lark Michael W. | Sr. VP, Research & CSO | 12/10/2014 | 20,000 |
| GOWEN MAXINE | President & CEO | 12/10/2014 | 32,000 |
| Alta Partners VIII, L.P. | 10% Owner | 12/10/2014 | 2,000,000 |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | 12/10/2014 | 4,000,000 |
| Deegan Rosamond | Sr VP, Bus Dev & Operations | 09/29/2014 | 308 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 08/14/2014 | 221,680 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 08/13/2014 | 34,884 |
| GOWEN MAXINE | President & CEO | 04/23/2014 | 84,893 |
| Forest Laboratories Holdings Ltd | 10% Owner | 02/05/2014 | 2,999,997 |
| New Enterprise Associates 12, Limited Partnership | 10% Owner | 02/05/2014 | 3,306,870 |
| Polaris Venture Management Co. V, L.L.C. | 10% Owner | 02/05/2014 | 3,306,835 |
| HealthCare Ventures VIII, L.P. | 10% Owner | 02/05/2014 | 2,079,406 |
| Alta Partners VIII, L.P. | 10% Owner | 02/05/2014 | 3,306,870 |
Load More Insider Transactions
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 06/30/2022
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
03/31/2022
0%
1Q
12/31/2021
1.37%
2Q
09/30/2021
1.67%
3Q
06/30/2021
2.21%
4Q
03/31/2021
3.12%
5Q
12/31/2020
29.70%
6Q
09/30/2020
40.97%
7Q
Load More